Correction to Novo Nordisk, Valo Health Article on Wednesday
Valo Health is eligible for a further $1.9 billion in potential milestone payments for up to nine new drug programs "Novo Nordisk, Valo Health Expand Drug Discovery and Development Pact -- Update," at ...
General Atlantic-backed biotech start-up secures $410mn in initial funding round
The Series A funding round by the start-up, co-founded by executives of Aiolos Bio, the biotech that was sold to GSK last ...